Clinical Features

BPH: Risk Factors, Aetiology and Management

Benign prostatic hyperplasia (BPH) is a term used to describe the nonmalignant growth or hyperplasia of prostate tissue.

Benign prostatic hyperplasia (BPH) is a term used to describe the nonmalignant growth or hyperplasia of prostate tissue.

Benign prostatic hyperplasia (BPH) is a term used to describe the nonmalignant growth or hyperplasia of prostate tissue. The condition is characterised by an increase in epithelial and stromal cells in the peri-urethral area of the prostate. BPH is the most common cause of bladder outlet obstruction (BOO) and LUTS in men. It is extremely common and the prevalence of histological BPH at autopsy is as high as 90 per cent in men aged 81-90 years.1

The resultant effects of BPH on men are in the form of LUTS; the prevalence of which can range between 44 per cent in men between the ages of 40-59, and increasing to 70 per cent in males over 80 years of age.

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free